Delivery Order SPE2DB24D2013-SPE2DB25FCGWZ

Award Date 11/22/24
Potential Completion Date 11/25/24
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,632.62, is for the delivery of 4,568,165,574 units of Epinephrine 0.3 mg Auto-Injectors. The contract is a firm fixed-price, non-set-aside delivery order with a performance period extending through May 8, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,263.53, is for the delivery of 4,563,268,505 units of Epinephrine 0.3 mg Auto-Injectors to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has a firm fixed-price pricing type and a completion...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,225.51 firm-fixed-price contract is for the supply of 4,567,199,649 units of Epinephrine 0.3 mg Auto-Injectors. The contract has an ultimate completion date of February 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,311.19, is for the delivery of 4,568,119,235 units of Epinephrine 0.3 mg auto-injectors. The contract has an ultimate completion date of May 5, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in SAM.gov and holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,460.99, is for the delivery of 4,568,038,467 units of Epinephrine 0.3 mg Auto-Injectors. The contract is a firm fixed-price delivery order with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a for-profit...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,610.63 firm-fixed-price contract is for the delivery of 4,565,484,157 units of Epinephrine 0.3 mg auto-injectors. The contract has an ultimate completion date of August 19, 2024 and was awarded on August 16, 2024. Amerisourcebergen, through its Corporate Office Division, has been awarded numerous federal contracts and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,588.72, is for the delivery of 4,564,912,693 units of Epinephrine 0.3 mg auto-injectors. The contract has an ultimate completion date of June 17, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,320.50, is for the delivery of 4,567,951,638 units of Epinephrine 0.3 mg auto-injectors. The contract has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,577.83 Firm Fixed Price Delivery Order is for the supply of 4,566,699,028 units of Epinephrine 0.3 mg Auto-Injectors. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,140.13, is for the delivery of epinephrine 0.3 mg auto-injectors. The contract is a firm fixed-price, delivery order contract with an ultimate completion date of August 22, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
  • SPE2DB24D2013
    Indefinite Delivery Contract
  • SPE2DB24D2013-SPE2DB25FCGWZ
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,712.80 fixed-price contract is for the delivery of 4,566,529,489 units of Epinephrine 0.3 mg Auto-Injectors. The contract has an ultimate completion date of November 25, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This delivery order is part of the company's broader role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.

Generated 2/21/25, 9:52 AM